AGLE
Aeglea Biotherapeutics, Inc.
10% owner Eli & Co Lilly bought $5.0M of Aeglea Biotherapeutics, Inc.
Bought$5,000,000
$10.00Price
500,000Shares
+24%Stake
What AGLE did for a copier
Prices for AGLE after this filing aren't in yet.
Eli & Co Lilly's record
2 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Apr 12. Filed Thu, Apr 14. Not investment advice.